About This Calculator

The 5-FU Dose Calculator is a clinical support tool for healthcare professionals to estimate patient-specific dosing for common chemotherapy regimens containing 5-Fluorouracil. It uses patient height and weight to calculate Body Surface Area (BSA) and subsequently determines the appropriate dose for each drug within a selected protocol, such as mFOLFOX6, FOLFIRI, or FOLFIRINOX. The tool also allows for standard dose modifications and BSA capping as per institutional guidelines.

Outputs Explained

Upon entering the required patient data, the calculator provides the following outputs:

• Calculated Doses: A clear breakdown of the final dose in milligrams (mg) for each component of the chosen regimen (e.g., Oxaliplatin, Leucovorin, 5-FU bolus, 5-FU infusion).
• Patient BSA: The calculated Body Surface Area (BSA) in m², which forms the basis for most dosing calculations. If a cap is applied, both the raw and capped BSA values are shown.
• Regimen Summary: A summary of the standard dose (e.g., mg/m²) for each drug and important administration notes, providing context for the final calculated values.
• Clinical Flags: Contextual warnings may appear if the calculated BSA is unusually high, a dose modification is applied, or if optional lab values (serum creatinine, bilirubin) exceed typical thresholds.

How to Use the Calculator

Follow these steps to calculate a patient's chemotherapy dose:

1. Enter Patient Metrics: Input the patient's height and weight. Select the appropriate units (cm/kg or ft+in/lbs) from the dropdown menus.
2. Select a Regimen: Choose the desired 5-FU based chemotherapy protocol (e.g., mFOLFOX6) from the regimen list.
3. Apply Dose Modifications: If a dose reduction is required due to toxicity or other clinical factors, select the appropriate percentage from the 'Dose Modification' dropdown.
4. Set Optional BSA Cap: To apply a maximum BSA for the calculation, check the 'Enable' box for BSA Capping and enter the maximum value (e.g., 2.0 m²).
5. Enter Optional Labs: Input serum creatinine and total bilirubin levels to receive contextual alerts regarding potential needs for renal or hepatic dose adjustments.
6. Review Results: The calculated doses for each drug will automatically appear in the output section. Always verify these results against institutional protocols and with a qualified pharmacist or oncologist.

Dosing Overview

Most cytotoxic chemotherapy agents, including 5-Fluorouracil, are dosed based on Body Surface Area (BSA) to normalize the dosage across patients of varying sizes. The calculator uses the Mosteller formula for this calculation. Each regimen has a standardized dose in mg/m² for its constituent drugs. For example, in the mFOLFOX6 regimen, Oxaliplatin is typically given at 85 mg/m², while the 5-FU infusion is given at 2400 mg/m². These standard doses are multiplied by the patient's BSA to determine the final administration dose.

Switching Between Regimens

The decision to switch a patient from one chemotherapy regimen to another (e.g., from FOLFIRI to mFOLFOX6) is based on clinical factors such as disease progression, unacceptable toxicity, or completion of a planned treatment course. This calculator can be used to determine the initial dosing for the new regimen by selecting it from the list. However, dose modifications may be necessary based on the patient's prior treatment history and current clinical status. Such decisions must be made by the treating oncologist.

Missed Dose Management

Managing a missed or delayed chemotherapy dose is a critical clinical decision that depends on the specific drug, the length of the delay, and the overall treatment plan. It is not appropriate to use this calculator to adjust for a missed dose. Any deviation from the planned administration schedule must be addressed directly by the patient's oncology care team, who can provide guidance based on the specific clinical context.

Safety Alerts

DPD Deficiency

Patients with Dihydropyrimidine Dehydrogenase (DPD) deficiency are at high risk for severe, life-threatening toxicity (e.g., mucositis, diarrhea, neutropenia) when treated with fluoropyrimidines like 5-FU. Pre-treatment testing for DPD deficiency should be considered in accordance with clinical guidelines.

Professional Verification Required

This tool is for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. All calculations must be independently verified by a qualified healthcare professional before any medication is administered.

Frequently Asked Questions

What BSA formula does the calculator use?

The calculator uses the Mosteller formula, which is widely accepted for BSA calculation in oncology: BSA (m²) = √([Height (cm) × Weight (kg)] / 3600).

What is the purpose of BSA capping?

BSA capping involves setting a maximum BSA value (e.g., 2.0 m² or 2.2 m²) for dose calculations. This practice is often implemented by institutions to prevent excessive toxicity and overdosing in patients with high body mass index (BMI), where BSA may not accurately reflect metabolic clearance.

Why is leucovorin included in many 5-FU regimens?

Leucovorin (folinic acid) is not a chemotherapy drug itself. It is used to enhance the cytotoxic effects of 5-FU by stabilizing the binding of a 5-FU metabolite to thymidylate synthase, a key enzyme in DNA synthesis, thereby increasing its efficacy.

What is the difference between the 5-FU bolus and infusion doses?

The bolus dose provides a high peak concentration of the drug, while the continuous infusion provides prolonged exposure. This combination is thought to have synergistic antitumor effects by targeting cancer cells in different phases of the cell cycle.

Does the calculator automatically adjust doses for renal or hepatic impairment?

No. The calculator allows you to enter lab values for serum creatinine and total bilirubin to provide a warning if they are elevated. However, it does not perform automatic dose adjustments. All adjustments for organ dysfunction must be made according to institutional guidelines and clinical judgment.

Can I use this calculator for pediatric patients?

This calculator is designed based on adult chemotherapy regimens. Pediatric dosing protocols can differ significantly. Use for pediatric patients is not recommended without consulting specialized pediatric oncology resources and protocols.

What does the CapeOx (Reference) regimen represent?

CapeOx uses Capecitabine, an oral prodrug that converts to 5-FU in the body, instead of intravenous 5-FU. It is included for reference, but dosing for Capecitabine is complex and may involve fixed-dose strategies. Always consult prescribing information for Capecitabine dosing.

Are the regimen doses in the calculator universally standard?

The doses provided represent commonly used standard regimens. However, protocols can vary between institutions and may be modified based on clinical trial data or patient-specific factors. Always verify doses with your local institutional protocols.

References

• Fluorouracil Injection, USP - FDA Prescribing Information. U.S. Food and Drug Administration.
• Fluorouracil - National Cancer Institute (NCI). National Institutes of Health.
• André T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350(23):2343-2351. doi:10.1056/NEJMoa032709
• Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364(19):1817-1825. doi:10.1056/NEJMoa1011923
• Ghosn M, Ibrahim T, Assi T, et al. Dihydropyrimidine dehydrogenase (DPD) deficiency and fluoropyrimidines-based chemotherapy: a narrative review. J Med Liban. 2017;65(4):229-234.